Pomerantz LLP launches investigation into Omeros Corporation
Law firm Pomerantz LLP has initiated an investigation into potential securities claims on behalf of Omeros Corporation investors.
New York-based law firm Pomerantz LLP has announced an investigation into Omeros Corporation regarding potential breaches of fiduciary duty or securities laws. The firm is currently seeking information from investors who held shares in the pharmaceutical company to evaluate the validity of potential claims.
This development follows increased scrutiny of corporate disclosures and market performance for Omeros, which trades on the NASDAQ exchange under the ticker OMER. Investigations of this nature are standard practice for the firm when assessing whether shareholders were misled by company communications or financial reporting.
Omeros Corporation has not issued a formal response to the investigation. Investors are encouraged to contact legal counsel to determine their eligibility for potential litigation as the firm gathers evidence.